Position in WVE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$232,400
-$57,600 QoQ
Shares Held
40,000
0.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#135
of 237 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WVE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Knott David M Jr holds $78,122,281 across 31 Biotechnology names. WVE ranks #30 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SNDX |
Syndax Pharmaceuticals Inc
|
437,245 | $9,558,175 | |
| 2 | TVTX |
Travere Therapeutics, Inc.
|
147,282 | $8,367,090 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
63,000 | $7,722,540 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
92,850 | $6,915,468 | |
| 5 | IOVA |
Iovance Biotherapeutics, Inc.
|
1,600,000 | $6,656,000 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
111,081 | $4,298,834 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
66,839 | $3,672,134 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
95,058 | $3,527,602 |
All Filings in WVE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $232,400 | 40,000 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $290,000 | 40,000 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,530,000 | 90,000 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $658,800 | 90,000 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $260,000 | 40,000 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $80,800 | 10,000 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||